Status:
COMPLETED
The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty
Lead Sponsor:
Paul Di Cesare,MD
Conditions:
Total Knee Replacement
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The investigators hypothesize that Arixtra patients will be less likely to experience wound infection than patients who have received low-molecular weight heparin, coumadin or aspirin with mechanical ...
Eligibility Criteria
Inclusion
- All primary unilateral TKA and THA cases will be included.
Exclusion
- Patients less than 50 kg, Patients with CrCl\<30ml/min. Revision and bilateral procedures will be excluded.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT00909064
Start Date
June 1 2009
End Date
December 1 2009
Last Update
May 15 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
U C Davis
Sacramento, California, United States, 95817